Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen

Advani, 2007, Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004, APMIS, 115, 299, 10.1111/j.1600-0463.2007.apm_556.x

Advani, 2007, Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype, APMIS, 115, 736, 10.1111/j.1600-0463.2007.apm_628.x

Advani, 2009, Analysis of Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage, J. Microb. Meth., 78, 297, 10.1016/j.mimet.2009.06.019

Anonymous, 1956, Vaccination against whooping-cough; relation between protection in children and results of laboratory tests; a report to the Whooping-cough Immunization Committee of the Medical Research Council and to the medical officers of health for Cardiff, Leeds, Leyton, Manchester, Middlesex, Oxford, Poole, Tottenham, Walthamstow, and Wembley, Br. Med. J., 2, 454

Ausiello, 1997, Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines, Infect. Immun., 65, 2168, 10.1128/IAI.65.6.2168-2174.1997

Bartoloni, 1988, Mapping of a protective epitope of pertussis toxin by in vitro refolding of recombinant fragments, Bio/Technology, 6, 709, 10.1038/nbt0688-709

Berbers, 2009, Improving pertussis vaccination, Hum. Vacc., 5, 38

Borisova, 2007, Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains, Clin. Vacc. Immunol., 14, 234, 10.1128/CVI.00294-06

Bottero, 2007, Pulse field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms and surfaceome analysis of vaccine and clinical Bordetella pertussis strains, Clin. Vacc. Immunol., 14, 1490, 10.1128/CVI.00177-07

Bouchez, 2009, First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin, Vaccine, 10.1016/j.vaccine.2009.07.074

Byrne, 2006, Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003, BMC Infect. Dis., 6, 53, 10.1186/1471-2334-6-53

Brinig, 2006, Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation, J. Bacteriol., 188, 2375, 10.1128/JB.188.7.2375-2382.2006

Carbonetti, 2007, Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease, Curr. Opin. Pharmacol., 7, 272, 10.1016/j.coph.2006.12.004

Caro, 2007, Pertussis in Argentina and France, Vaccine, 25, 4335, 10.1016/j.vaccine.2006.08.024

Caro, 2006, Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization, Microb. Infect., 8, 2228, 10.1016/j.micinf.2006.04.014

Caro, 2005, Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies, Microb. Infect., 7, 976, 10.1016/j.micinf.2005.04.005

Carroll, 2008, Evo-devo and an expanding evolutionary synthesis: a genetic theory of morphological evolution, Cell, 134, 25, 10.1016/j.cell.2008.06.030

Cassiday, 2000, Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935–1999, J. Infect. Dis., 182, 1402, 10.1086/315881

Charles, 1991, Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis, Eur. J. Immunol., 21, 1147, 10.1002/eji.1830210509

Cherry, 1998, A search for serologic correlates of immunity to Bordetella pertussis cough illnesses, Vaccine, 16, 1901, 10.1016/S0264-410X(98)00226-6

Cornelius, 2009, Yersinia pestis IS1541 transposition provides for escape from plague immunity, Infect. Immun., 77, 1807, 10.1128/IAI.01162-08

Cromer, 1993, Unrecognized pertussis infection in adolescents, Am. J. Dis. Child., 147, 575

Cummings, 2004, Bordetella species are distinguished by patterns of substantial gene loss and host adaptation, J. Bacteriol., 186, 1484, 10.1128/JB.186.5.1484-1492.2004

Cummings, 2006, Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS, J. Bacteriol., 188, 1775, 10.1128/JB.188.5.1775-1785.2006

Curry, 2007, tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile, J. Clin. Microbiol., 45, 215, 10.1128/JCM.01599-06

Dalet, 2004, Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate, Infect. Immun., 72, 4874, 10.1128/IAI.72.8.4874-4877.2004

David, 2004, Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model, Vaccine, 22, 1892, 10.1016/j.vaccine.2003.11.005

Davison, 2005, Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?, Expert Rev. Vacc., 4, 77, 10.1586/14760584.4.1.77

Deen, 1995, Household contact study of Bordetella pertussis infections, Clin. Infect. Dis., 21, 1211, 10.1093/clinids/21.5.1211

de Greeff, 2008, Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands, Pediatr. Infect. Dis. J., 27, 218, 10.1097/INF.0b013e318161a2b9

De Magistris, 1992, Interaction of the pertussis toxin peptide containing residues 30–42 with DR1 and the T-cell receptors of 12 human T-cell clones, Proc. Natl. Acad. Sci. U.S.A., 89, 2990, 10.1073/pnas.89.7.2990

De Magistris, 1991, Human T cell immunity against Bordetella pertussis analyzed at clonal level, Ann. Ist Super. Sanita, 27, 33

De Magistris, 1989, Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map, J. Exp. Med., 169, 1519, 10.1084/jem.169.5.1519

de Melker, 2006, The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys, J. Infect., 53, 106, 10.1016/j.jinf.2005.10.020

De Schutter, 2003, Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members, Clin. Infect. Dis., 36, 1391, 10.1086/375071

Diavatopoulos, 2005, Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica, PLoS Pathog., 1, 373, 10.1371/journal.ppat.0010045

Diavatopoulos, 2006, Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes, J. Bacteriol., 188, 8385, 10.1128/JB.01081-06

Di Tommaso, 1994, Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing, Infect. Immun., 62, 1830, 10.1128/IAI.62.5.1830-1834.1994

Edwards, 2004, Pertussis vaccine

Edwards, 1995, Comparison of 13 acellular pertussis vaccines: overview and serologic response, Pediatrics, 96, 548, 10.1542/peds.96.3.548

Electronic, 2009. http://www.hpa.org.uk/infections/topics_az/whoopingcough/data_not_death.htm.

Elomaa, 2005, Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years, J. Clin. Microbiol., 43, 3681, 10.1128/JCM.43.8.3681-3687.2005

Elomaa, 2007, Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories, Vaccine, 25, 918, 10.1016/j.vaccine.2006.09.012

Ewald, 1994

Fazekas, 1966, Disquisitions of original antigenic sin. I. Evidence in man, J. Exp. Med., 124, 331, 10.1084/jem.124.3.331

Fingermann, 2006, Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production, Vaccine, 24, 3513, 10.1016/j.vaccine.2006.02.026

Frank, 2008, Mechanisms of pathogenesis and the evolution of parasite virulence, J. Evol. Biol., 21, 396, 10.1111/j.1420-9101.2007.01480.x

Fry, 2001, Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom, Infect. Immun., 69, 5520, 10.1128/IAI.69.9.5520-5528.2001

Gandon, 2008, Evidences of parasite evolution after vaccination, Vaccine, 26, C4, 10.1016/j.vaccine.2008.02.007

Gandon, 2001, Imperfect vaccines and the evolution of pathogen virulence, Nature, 414, 751, 10.1038/414751a

Geuijen, 1997, Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract, Infect. Immun., 65, 4222, 10.1128/IAI.65.10.4222-4228.1997

Geuijen, 1998, Identification and characterization of heparin binding regions of the Fim2 subunit of Bordetella pertussis, Infect. Immun., 66, 2256, 10.1128/IAI.66.5.2256-2263.1998

Geuijen, 1996, The major fimbrial subunit of Bordetella pertussis binds to sulfated sugars, Infect. Immun., 64, 2657, 10.1128/IAI.64.7.2657-2665.1996

Gogol, 2007, Phase variation and microevolution at homopolymeric tracts in Bordetella pertussis, BMC Genom., 8, 122, 10.1186/1471-2164-8-122

Goodnow, 1980, Biology of Bordetella bronchiseptica, Microbiol. Rev., 44, 722, 10.1128/MMBR.44.4.722-738.1980

Granstrom, 1993, Serological correlates in whooping cough, Vaccine, 11, 445, 10.1016/0264-410X(93)90286-7

Greenberg, 2005, Health burden of pertussis in infants and children, Pediatr. Infect. Dis. J., 24, S39, 10.1097/01.inf.0000160911.65632.e1

Guiso, 2001, Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines, Vaccine, 19, 3248, 10.1016/S0264-410X(01)00013-5

Gzyl, 2004, Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates, Vaccine, 22, 2122, 10.1016/j.vaccine.2003.12.006

Gzyl, 2001, Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland, Vaccine, 20, 299, 10.1016/S0264-410X(01)00356-5

Hallander, 2007, Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis, J. Clin. Microbiol., 45, 3257, 10.1128/JCM.00864-07

Hallander, 2005, Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs, J. Clin. Microbiol., 43, 2856, 10.1128/JCM.43.6.2856-2865.2005

Hallander, 2005, Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2–6 1/2 years after the third vaccine dose, Vaccine, 23, 5359, 10.1016/j.vaccine.2005.06.009

Halperin, 2007, The control of pertussis – 2007 and beyond, N. Engl. J. Med., 356, 110, 10.1056/NEJMp068288

Han, 2008, Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan, Vaccine, 26, 1530, 10.1016/j.vaccine.2008.01.020

Hardwick, 2002, Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999, Emerg. Infect. Dis., 8, 44, 10.3201/eid0801.010021

Hausman, 2000, Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization, Infect. Immun., 68, 3763, 10.1128/IAI.68.6.3763-3767.2000

Hazenbos, 1995, Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimD, J. Infect. Dis., 171, 924, 10.1093/infdis/171.4.924

Hazenbos, 1995, Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases, J. Immunol., 155, 3972, 10.4049/jimmunol.155.8.3972

He, 2008, Factors contributing to pertussis resurgence, Future Microbiol., 3, 329, 10.2217/17460913.3.3.329

Heikkinen, 2007, Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains, PLoS ONE, 2, e904, 10.1371/journal.pone.0000904

Hewlett, 1996, Acellular pertussis trial, Pediatrics, 98, 800, 10.1542/peds.98.4.800

Hijnen, 2007, The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition, Vaccine, 25, 5902, 10.1016/j.vaccine.2007.05.039

Hodder, 2000, Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents, Clin. Infect. Dis., 31, 7, 10.1086/313913

Holmes, 2000, Biology and molecular epidemiology of diphtheria toxin and the tox gene, J. Infect. Dis., 181, S156, 10.1086/315554

Hozbor, D., Mooi, F., Flores, D., Weltman, G., Bottero, D., Fossati, S., Lara, C., Gaillard, M.E., Pianciola, L., Zurita, E., Fioriti, A., Archuby, D., Galas, M., Binsztein, N., Regueira, M., Castuma, C., Fingermann, M., Graieb, A., 2009. Pertussis epidemiology in Argentina trends over 2004–2007. J. Infect. (online).

Iwata, 1991, Mixed outbreak of Bordetella pertussis and Bordetella parapertussis in an apartment house, Dev. Biol. Stand., 73, 333

Jacob-Dubuisson, 2007, The Bordetella adhesins, 69

King, 2001, Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity, Microbiology, 147, 2885, 10.1099/00221287-147-11-2885

King, 2008, Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains, BMC Genom., 9, 311, 10.1186/1471-2164-9-311

Kirimanjeswara, 2005, Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis, J. Clin. Invest., 115, 3594, 10.1172/JCI24609

Kodama, 2004, Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan, J. Clin. Microbiol., 42, 5453, 10.1128/JCM.42.12.5453-5457.2004

Kolodkina, 2007, Point mutations in tox promoter/operator and diphtheria toxin repressor (DTXR) gene associated with the level of toxin production by Corynebacterium diphtheriae strains isolated in Belarus, Mol. Gen. Mikrobiol. Virusol., 1, 22

Kourova, 2003, Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains, J. Clin. Microbiol., 41, 3706, 10.1128/JCM.41.8.3706-3711.2003

Lapin, 1943

Lawrence, 2005, Common themes in the genome strategies of pathogens, Curr. Opin. Genet. Dev., 15, 584, 10.1016/j.gde.2005.09.007

Lederberg, 2000, Infectious history, Science, 288, 287, 10.1126/science.288.5464.287

Lee, 2003, Molecular epidemiology of Bordetella pertussis isolated in Taiwan, 1992–1997, Microbiol. Immunol., 47, 903, 10.1111/j.1348-0421.2003.tb03463.x

Leininger, 1992, Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin, Infect. Immun., 60, 2380, 10.1128/IAI.60.6.2380-2385.1992

Leininger, 1991, Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells, Proc. Natl. Acad. Sci. U.S.A., 88, 345, 10.1073/pnas.88.2.345

Li, 2009, Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus, Proc. Natl. Acad. Sci. U.S.A., 106, 5883, 10.1073/pnas.0900743106

Lipsitch, 2007, Patterns of antigenic diversity and the mechanisms that maintain them, J. R. Soc. Interface, 4, 787, 10.1098/rsif.2007.0229

Litt, 2009, Changes in genetic diversity of the UK Bordetella pertussis population between 1920 and 2006 reflect vaccination coverage and the emergence of a single dominant clonal type, J. Clin. Microbiol., 47, 680, 10.1128/JCM.01838-08

Luttinger, 1916, The epidemiology of pertussis, Am. J. Dis. Child., 12, 290, 10.1001/archpedi.1916.04110150088007

Mackinnon, 2004, Immunity promotes virulence evolution in a malaria model, PLoS Biol., 2, E230, 10.1371/journal.pbio.0020230

Magner, 1993, 392

Maharjan, 2008, Genome-wide analysis of single nucleotide polymorphisms in Bordetella pertussis using comparative genomic sequencing, Res. Microbiol., 159, 602, 10.1016/j.resmic.2008.08.004

Makinen, 2005, Bordetella pertussis isolates, Finland, Emerg. Infect. Dis., 11, 183, 10.3201/eid1101.040632

Makinen, 2003, PFGE and pertactin gene sequencing suggest limited genetic variability within the Finnish Bordetella parapertussis population, J. Med. Microbiol., 52, 1059, 10.1099/jmm.0.05434-0

Mascart, 2007, Modulation of the infant immune responses by the first pertussis vaccine administrations, Vaccine, 25, 391, 10.1016/j.vaccine.2006.06.046

Mastrantonio, 1999, Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children, Microbiology, 145, 2069, 10.1099/13500872-145-8-2069

Maurelli, 1998, “Black holes” and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli, Proc. Natl. Acad. Sci. U.S.A., 95, 3943, 10.1073/pnas.95.7.3943

Mazurova, 2005, Molecular genetic characteristics of the B. pertussis strains isolated in different periods of the pertussis epidemic process, J. Mol. Gen. Microb. Virol. (Moscow, Russia), 4, 21

McDonald, 2005, An epidemic, toxin gene-variant strain of Clostridium difficile, N. Engl. J. Med., 353, 2433, 10.1056/NEJMoa051590

McIntyre, 2009, Pertussis in early infancy: disease burden and preventive strategies, Curr. Opin. Infect. Dis., 22, 215, 10.1097/QCO.0b013e32832b3540

Mertsola, 1985, Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland, Eur. J. Clin. Microbiol., 4, 123, 10.1007/BF02013576

Mielcarek, 1998, Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis, Nat. Biotechnol., 16, 454, 10.1038/nbt0598-454

Miller, 1992, The epidemiology of pertussis in England and Wales, Commun. Dis. Rep. CDR Rev., 2, R152

Miller, 1943, An agglutinative reaction for Hemophilus pertussis. II. Its relation to clinical immunity, J. Pediatr., 22, 644, 10.1016/S0022-3476(43)80220-1

Mira, 2006, The neolithic revolution of bacterial genomes, Trends Microbiol., 14, 200, 10.1016/j.tim.2006.03.001

Mooi, 2007, The case for maternal vaccination against pertussis, Lancet Infect. Dis., 7, 614, 10.1016/S1473-3099(07)70113-5

Mooi, 2007, Phylogeny, evolution, and epidemiology of Bordetellae, 17

Mooi, 1999, Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland, Infect. Immun., 67, 3133, 10.1128/IAI.67.6.3133-3134.1999

Mooi, 2001, Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?, Emerg. Infect. Dis., 7, 526, 10.3201/eid0703.010308

Mooi, 2009, Bordetella pertussis with increased pertussis toxin production associated with pertussis resurgence, Emerg. Infect. Dis., 15, 1206, 10.3201/eid1508.081511

Mooi, 1998, Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution, Infect. Immun., 66, 670, 10.1128/IAI.66.2.670-675.1998

Moran, 2004, Genomic changes following host restriction in bacteria, Curr. Opin. Genet. Dev., 14, 627, 10.1016/j.gde.2004.09.003

Muyldermans, 2001, Polymorphism of Belgian Bordetella pertussis isolates, J. Microb. Meth., 47, 108

Njamkepo, 2008, Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas, Microb. Infect., 10, 1582, 10.1016/j.micinf.2008.09.012

Njamkepo, 2002, Thirty-five years’ experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity, Vaccine, 20, 1290, 10.1016/S0264-410X(01)00479-0

Orr, 2005, The genetic theory of adaptation: a brief history, Nat. Rev. Genet., 6, 119, 10.1038/nrg1523

Osborne, 2009, Pathogenic adaptation of intracellular bacteria by rewiring a cis-regulatory input function, Proc. Natl. Acad. Sci. U.S.A., 106, 3982, 10.1073/pnas.0811669106

Packard, 2004, Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK, J. Med. Microbiol., 53, 355, 10.1099/jmm.0.05515-0

Parkhill, 2003, Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica, Nat. Genet., 35, 32, 10.1038/ng1227

Peppler, 2003, Strain variation among Bordetella pertussis isolates from Quebec and Alberta provinces of Canada from 1985 to 1994, J. Clin. Microbiol., 41, 3344, 10.1128/JCM.41.7.3344-3347.2003

Peppoloni, 1995, Acellular pertussis vaccine composed of genetically inactivated pertussis toxin, Physiol. Chem. Phys. Med. NMR, 27, 355

Perez, 2009, Transcription factor function and promoter architecture govern the evolution of bacterial regulons, Proc. Natl. Acad. Sci. U.S.A., 106, 4319, 10.1073/pnas.0810343106

Pierce, 2000, Is leukocytosis a predictor of mortality in severe pertussis infection?, Intensive Care Med., 26, 1512, 10.1007/s001340000587

Porter, 1996, Differentiation between human and ovine isolates of Bordetella parapertussis using pulsed-field gel electrophoresis, FEMS Microbiol. Lett., 135, 131, 10.1111/j.1574-6968.1996.tb07977.x

Poynten, 2004, Temporal trends in circulating Bordetella pertussis strains in Australia, Epidemiol. Infect., 132, 185, 10.1017/S095026880300164X

Preston, 1985, Essential immunogens in human pertussis: the role of fimbriae, Dev. Biol. Stand., 61, 137

Preziosi, 2002, Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program, Am. J. Epidemiol., 155, 891, 10.1093/aje/155.10.891

Riboli, 1991, Expression of Bordetella pertussis fimbrial (fim) genes in Bordetella bronchiseptica: fimX is expressed at a low level and vir-regulated, Microb. Pathog., 10, 393, 10.1016/0882-4010(91)90084-N

Roush, 2007, Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States, J. Am. Med. Assoc., 298, 2155, 10.1001/jama.298.18.2155

Ryan, 1998, Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children, Immunology, 93, 1, 10.1046/j.1365-2567.1998.00401.x

Sako, 1947, Studies on pertussis immunization, J. Pediatr., 30, 29, 10.1016/S0022-3476(47)80280-X

Schouls, 2008, Two variants among Haemophilus influenzae serotype b strains with distinct bcs4, hcsA and hcsB genes display differences in expression of the polysaccharide capsule, BMC Microbiol., 8, 35, 10.1186/1471-2180-8-35

Schouls, 2004, Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s, J. Bacteriol., 186, 5496, 10.1128/JB.186.16.5496-5505.2004

Smith, 2009, Myths and misconceptions: the origin and evolution of Mycobacterium tuberculosis, Nat. Rev. Microbiol., 7, 537, 10.1038/nrmicro2165

Soto, 2004, IS6110 mediates increased transcription of the phoP virulence gene in a multidrug-resistant clinical isolate responsible for tuberculosis outbreaks, J. Clin. Microbiol., 42, 212, 10.1128/JCM.42.1.212-219.2004

Stefanelli, 2009, A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells, New Microbiol., 32, 159

Stibitz, 1989, Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-component system, Nature, 338, 266, 10.1038/338266a0

Stibitz, 2007, The bvg regulon, 47

Stibitz, 1997, Genomic fluidity of Bordetella pertussis assessed by a new method for chromosomal mapping, J. Bacteriol., 179, 5820, 10.1128/jb.179.18.5820-5826.1997

Still, 1931

Storsaeter, 1998, Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis, Vaccine, 16, 1907, 10.1016/S0264-410X(98)00227-8

Streefland, 2007, PAT for vaccines: the first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease, Vaccine, 25, 2994, 10.1016/j.vaccine.2007.01.015

Streisinger, 1985, Mechanisms of spontaneous and induced frameshift mutation in bacteriophage T4, Genetics, 109, 633, 10.1093/genetics/109.4.633

Taranger, 2001, Mass vaccination of children with pertussis toxoid – decreased incidence in both vaccinated and nonvaccinated persons, Clin. Infect. Dis., 33, 1004, 10.1086/322639

Taranger, 2000, Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis, J. Infect. Dis., 181, 1010, 10.1086/315318

Tsang, 2004, Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada, J. Clin. Microbiol., 42, 5364, 10.1128/JCM.42.11.5364-5367.2004

Tsang, 2005, Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine, Can. J. Microbiol., 51, 887, 10.1139/w05-079

Uria, 2008, A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies, J. Exp. Med., 205, 1423, 10.1084/jem.20072577

van Amersfoorth, 2005, Analysis of Bordetella pertussis populations in European countries with different vaccination policies, J. Clin. Microbiol., 43, 2837, 10.1128/JCM.43.6.2837-2843.2005

Vandebriel, 2003, Association of Bordetella pertussis with host immune cells in the mouse lung, Microb. Pathog., 35, 19, 10.1016/S0882-4010(03)00087-1

van der Zee, 1996, The differentiation of Bordetella parapertussis and Bordetella bronchiseptica from humans and animals as determined by DNA polymorphism mediated by two different insertion sequence elements suggests their phylogenetic relationship, Int. J. Syst. Bacteriol., 46, 640, 10.1099/00207713-46-3-640

van der Zee, 1997, Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences, J. Bacteriol., 179, 6609, 10.1128/jb.179.21.6609-6617.1997

van Gent, 2009, An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands, Vaccine, 27, 1898, 10.1016/j.vaccine.2009.01.111

van Gent, 2007, Characterization of Bordetella pertussis clinical isolates that do not express the tracheal colonization factor, FEMS Immunol. Med. Microbiol., 51, 149, 10.1111/j.1574-695X.2007.00291.x

van Loo, 2002, Multilocus sequence typing of Bordetella pertussis based on surface protein genes, J. Clin. Microbiol., 40, 1994, 10.1128/JCM.40.6.1994-2001.2002

van Loo, 2002, Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines, Microbiology, 148, 2011, 10.1099/00221287-148-7-2011

van Loo, 1999, Temporal trends in the population structure of Bordetella pertussis during 1949–1996 in a highly vaccinated population, J. Infect. Dis., 179, 915, 10.1086/314690

Ward, 2006, Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT), Clin. Infect. Dis., 43, 151, 10.1086/504803

Warny, 2005, Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe, Lancet, 366, 1079, 10.1016/S0140-6736(05)67420-X

Watanabe, 2002, Effect of acellular pertussis vaccine against various strains of Bordetella pertussis in a murine model of respiratory infection, J. Health Sci., 48, 560, 10.1248/jhs.48.560

Watanabe, 2004, Whooping cough due to Bordetella parapertussis: an unresolved problem, Expert Rev. Anti-Infect. Ther., 2, 447, 10.1586/14787210.2.3.447

Weber, 2001, Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years, J. Clin. Microbiol., 39, 4396, 10.1128/JCM.39.12.4396-4403.2001

WHO, 2006, Challenges in global immunization and the Global Immunization Vision and Strategy 2006–2015, Weekly Epidemiol. Rec., 81, 190

Willems, 1990, Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation, EMBO J., 9, 2803, 10.1002/j.1460-2075.1990.tb07468.x

Winfield, 2004, Phenotypic differences between Salmonella and Escherichia coli resulting from the disparate regulation of homologous genes, Proc. Natl. Acad. Sci. U.S.A., 101, 17162, 10.1073/pnas.0406038101

Wisniewski-Dye, 2008, Phase and antigenic variation mediated by genome modifications, A. v. Leeuw., 94, 493, 10.1007/s10482-008-9267-6

Wright, 2007, The antibiotic resistome: the nexus of chemical and genetic diversity, Nat. Rev. Microbiol., 5, 175, 10.1038/nrmicro1614

Yao, 2005, Antigenic divergence of Bordetella pertussis isolates in Taiwan, J. Clin. Microbiol., 43, 5457, 10.1128/JCM.43.11.5457-5461.2005